Will CTI BioPharma Corp (CTIC) Outperform the Rest of the Stocks in the Healthcare Sector?

Monday, June 05, 2023 12:58 PM | InvestorsObserver Analysts

Mentioned in this article

Will CTI BioPharma Corp (CTIC) Outperform the Rest of the Stocks in the Healthcare Sector?

A rating of 87 puts CTI BioPharma Corp (CTIC) near the top of the Healthcare sector according to InvestorsObserver. CTI BioPharma Corp's score of 87 means that it ranks higher than 87% of stocks in the sector. In addition, its overall score of 97 ranks it higher than 97% of all stocks.

CTIC has an Overall Score of 97. Find out what this means to you and get the rest of the rankings on CTIC!

See Full CTIC Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 97 means the stock is more attractive than 97 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With CTI BioPharma Corp Stock Today?

CTI BioPharma Corp (CTIC) stock is unchanged 0% while the S&P 500 is up 0.37% as of 12:58 PM on Monday, Jun 5. CTIC is unchanged $0.00 from the previous closing price of $9.05 on volume of 574,790 shares. Over the past year the S&P 500 is higher by 4.29% while CTIC is up 73.70%. CTIC lost -$0.58 per share the over the last 12 months. Click Here to get the full Stock Report for CTI BioPharma Corp stock.